BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29496597)

  • 1. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
    Cambau E; Saunderson P; Matsuoka M; Cole ST; Kai M; Suffys P; Rosa PS; Williams D; Gupta UD; Lavania M; Cardona-Castro N; Miyamoto Y; Hagge D; Srikantam A; Hongseng W; Indropo A; Vissa V; Johnson RC; Cauchoix B; Pannikar VK; Cooreman EAWD; Pemmaraju VRR; Gillini L;
    Clin Microbiol Infect; 2018 Dec; 24(12):1305-1310. PubMed ID: 29496597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
    Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.
    Ahuja M; Singh I; Lavania M; Pathak VK; Darlong J; Turankar RP; Hembrom S; Singh SV; Sengupta U
    J Glob Antimicrob Resist; 2022 Sep; 30():282-285. PubMed ID: 35717020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
    Andrade ESN; Brandão JG; Silva JSD; Coriolano CRF; Rosa PS; Moraes MO; Ferreira CO; Gomes CM; Araújo WN
    Antimicrob Agents Chemother; 2022 May; 66(5):e0217021. PubMed ID: 35435708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
    Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
    Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.
    Chhabra S; Narang T; Sahu S; Sharma K; Shilpa S; Sharma A; Jain S; Singh I; Yadav R; Kaur M; Sharma R; Nadeem M; Pandey P; Minz RW; Dogra S
    J Glob Antimicrob Resist; 2023 Dec; 35():262-267. PubMed ID: 37852372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
    Lavania M; Singh I; Turankar RP; Ahuja M; Pathak V; Sengupta U; Das L; Kumar A; Darlong J; Nathan R; Maseey A
    J Glob Antimicrob Resist; 2018 Mar; 12():214-219. PubMed ID: 29097343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
    Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
    Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.
    Li X; Li G; Yang J; Jin G; Shao Y; Li Y; Wei P; Zhang L
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
    Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
    Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for
    Mahajan NP; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh BN; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
    Am J Trop Med Hyg; 2020 Mar; 102(3):547-552. PubMed ID: 31933458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015.
    Chauffour A; Lecorche E; Reibel F; Mougari F; Raskine L; Aubry A; Jarlier V; Cambau E;
    Clin Microbiol Infect; 2018 Nov; 24(11):1213.e5-1213.e8. PubMed ID: 29906598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients.
    Chen X; He J; Liu J; You Y; Yuan L; Wen Y
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007946. PubMed ID: 31881061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI; Colorado CL; Torres JF; León CI
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
    Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
    Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
    Araujo S; Goulart LR; Truman RW; Goulart IMB; Vissa V; Li W; Matsuoka M; Suffys P; Fontes AB; Rosa PS; Scollard DM; Williams DL
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005506. PubMed ID: 28570560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL; Araujo S; Stryjewska BM; Scollard D
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.
    Cambau E; Bonnafous P; Perani E; Sougakoff W; Ji B; Jarlier V
    Clin Infect Dis; 2002 Jan; 34(1):39-45. PubMed ID: 11731943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
    Marijke Braet S; Jouet A; Aubry A; Van Dyck-Lippens M; Lenoir E; Assoumani Y; Baco A; Mzembaba A; Cambau E; Vasconcellos SEG; Rigouts L; Suffys PN; Hasker E; Supply P; de Jong BC
    Lancet Microbe; 2022 Sep; 3(9):e693-e700. PubMed ID: 35850123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multi-drug resistant Mycobacterium leprae from patients with leprosy].
    Maeda S
    Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.